Fortify

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the topical application in adults and children aged 12 years and older. It is to be applied in a thick layer to the throat and chest. For enhanced efficacy, the area may be covered with a warm, dry cloth. It is recommended that clothing around the throat and chest be loose to facilitate the inhalation of vapors.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for the medication is up to three times daily, or as directed by a healthcare professional. For children under 12 years of age, it is advised to consult a doctor prior to administration to determine the appropriate dosage and ensure safety.

Contraindications

Use of this product is contraindicated in patients with epilepsy due to the potential for exacerbating seizures. Additionally, it should not be used in individuals with high blood pressure, as it may pose further health risks.

When utilizing this product, it is essential to avoid heating, microwaving, or using it near an open flame. Furthermore, adding the product to hot water or any container containing heated water is contraindicated, as this may lead to splattering and result in burns.

Warnings and Precautions

For external use only; ingestion or nasal application is strictly prohibited. The product is flammable and must be kept away from fire or flame to prevent hazards.

Caution is advised for individuals with a history of epilepsy or high blood pressure, as the use of this product is contraindicated in these populations.

Healthcare professionals should instruct patients to discontinue use and seek medical advice if a cough persists for more than one week, recurs, or is accompanied by fever, rash, or a persistent headache. A persistent cough may indicate an underlying serious condition that requires further evaluation.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only and should not be ingested or placed in the nostrils. It is also flammable; therefore, it must be kept away from fire or flame.

In clinical practice, patients are advised to stop using the product and consult a healthcare professional if a cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache. A persistent cough may indicate a serious underlying condition that requires medical evaluation.

Before using this product, patients should seek medical advice if they have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema, or if the cough is accompanied by excessive phlegm (mucus). These conditions may necessitate a different therapeutic approach or further investigation.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Fortify (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and children aged 12 years and older, the recommended application is to rub a thick layer on the throat and chest, with a maximum frequency of three times daily or as directed by a healthcare provider.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should not use this product. The potential risks associated with the use of this medication during pregnancy have not been established, and there is insufficient data to determine its safety for fetal outcomes. Therefore, healthcare professionals are advised to counsel women of childbearing potential regarding the importance of avoiding this product during pregnancy and lactation.

Lactation

Lactating mothers are advised against the use of this product while breastfeeding. There is no available data on the excretion of this product in human milk or its effects on breastfed infants. Therefore, caution is warranted, and alternative treatments should be considered for lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, altered mental status, or any unusual physiological responses.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while no specific overdosage information is provided, healthcare professionals should exercise caution and be prepared to act swiftly in the event of an overdose, ensuring that appropriate measures are taken to safeguard patient health.

Nonclinical Toxicology

If pregnant or breast-feeding, the use of this product is contraindicated due to potential teratogenic effects. No relevant information is available regarding non-teratogenic effects, nonclinical toxicology, or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that this product should not be used by individuals with epilepsy or those who have high blood pressure.

Patients should be instructed to discontinue use and consult a doctor if their cough persists for more than one week, tends to recur, or is accompanied by symptoms such as fever, rash, or a persistent headache, as these may indicate a serious underlying condition.

When discussing the use of this product, healthcare providers should emphasize that it should not be heated, microwaved, or used near an open flame. Patients should also be cautioned against adding the product to hot water or any container where water is being heated, as this may cause splattering and result in burns.

Additionally, healthcare providers should recommend that patients consult a doctor before using the product if they have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema. Patients should also be advised to seek medical advice if their cough is accompanied by excessive phlegm (mucus).

Storage and Handling

The product is available in various packaging configurations, and the National Drug Code (NDC) numbers are provided for reference. It is essential to store the product in a tightly closed container to maintain its integrity. The recommended storage condition is at room temperature, away from heat sources.

Additionally, the organization supports recycling initiatives; therefore, users are encouraged to recycle the packaging where possible.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Fortify, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)